By the time-kill curve method, the combinations of vancomycin-gentamicin and vancomycin-tobramycin were shown to be synergistic against a majority of methicillin-susceptible and -resistant strains of Staphylococcus aureus.
obtained from Bristol Laboratories, and nafcillin was obtained from Wyeth Laboratories. A standard stock solution of each antibiotic was prepared according to the manufacturer's instructions, stored at -80°C, and thawed immediately before use.
The minimal inhibitory concentration (MIC) and minimal bactericidal concentration ( colony counts) was used. Synergism between vancomycin and gentamicin and between vancomycin and tobramycin was demonstrated for the majority of the strains. The synergistic effect was more pronounced at 24 and 48 h (Fig. 1) . There appeared to be no difference between the methicillin-susceptible and methicillin-resistant strains. Antagonism between vancomycin and gentamicin was demonstrated against one methicillin-susceptible strain at 24 h only. Vancomycin and tobramycin showed antagonism against three methicillin-resistant strains at 48 h only.
The results of this study confirmed the findings of enhanced activity of vancomycin-gentamicin and vancomycin-tobramycin against methicillin-susceptible S. aureus by the checkerboard method reported previously (9) . These findings extended to methicillin-resistant strains as well. Many of the S. aureus strains used in this study were tolerant to vancomycin (7, 10) . The synergistic effect appeared to be more pronounced with the tolerant strains. There also appeared to be no difference between strains that were susceptible and resistant to gentamicin and tobramycin.
Vancomycin alone appears to be an excellent antibiotic in the therapy of serious S. aureus infections in patients who are allergic to penicillin and in whom the infecting S. aureus strain is resistant to methicillin (8a 
